GlassScriptPhysician profile
Arti Sangave
NPI 1326487307
$1,077.47
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $137 · 2020: $80.43 · 2021: $13.88 · 2022: $89.93 · 2024: $756.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $573 · Food and Beverage: $183.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $573.05 |
| Food and Beverage | $183.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $692.92 | 2024 | Somatom Go.Top |
| Intuitive Surgical, INC. | $89.93 | 2022 | |
| Jazz Pharmaceuticals INC. | $61.78 | 2020-2024 | |
| Amgen INC. | $57.01 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $38.45 | 2019-2020 | |
| Novocure INC. | $32.71 | 2020-2021 | |
| Genzyme Corporation | $26.31 | 2019 | |
| Pfizer INC. | $25.68 | 2019-2020 | |
| Incyte Corporation | $18.67 | 2024 | Jakafi |
| Secura Bio, INC. | $17.15 | 2019 | |
| Daiichi Sankyo INC. | $16.86 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arti Sangave listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.